An Eastern Cape study conducted among 108 co-infected XDR-TB patients, started on treatment between 2006 and 2008, described the median CD4 count at treatment start as 215 cells/mm3 [20], with some counts as low as 40 cells/mm3. The gene discussed is CD4; the disease is tuberculosis.